Company Profile
live
MediumLoqus23 Therapeutics Limited
11914774•Private Limited With Share Capital
Suite 7 Mcclintock Building, Granta Park, Great Abington, CB216GP
Get Full Access
Incorporated
29/03/2019
Company Age
7 years
Directors
5
Employees
7
SIC Code
72110
Risk
very low risk
Company Overview
Registration, classification & business activity
Loqus23 Therapeutics Limited (11914774) is a private limited with share capital incorporated on 29/03/2019 (7 years old) and registered in great abington, CB216GP. The company operates under SIC code 72110 - research and experimental development on biotechnology.
Loqus23 are discovering oral small molecule therapies targeting aberrant dna mismatch repair to effectively treat huntington’s and other triplet repeat diseases.
Private Limited With Share Capital
SIC: 72110
Medium
Incorporated 29/03/2019
CB216GP
7 employees
Financial Overview
Total Assets
£17.60M
Liabilities
£790.7K
Net Assets
£16.81M
Cash
£12.48M
Key Metrics
7
Employees
5
Directors
22
Shareholders
2
Patents
Board of Directors
5
Name
Position
director
director
director
director
director
Charges
3
Registered
1
Outstanding
0
Part Satisfied
2
Satisfied
Import / Export
Imports
12 Months1
60 Months2
Exports
12 Months0
60 Months7
Risk Assessment
very low risk
International Score
Future Factor
excellent
Performance Rating
Accounts
Typesmall company
Due Date31/12/2026
Filing Date19/07/2025
Latest Accounts31/03/2025
Trading Addresses
Suite 7 Mcclintock Building, Granta Park, Great Abington, Cambridgeshire Cb21 6Gp, CB216GPRegistered
Babraham Hall, Babraham, Cambridge, Cambridgeshire, CB223AT
Related Companies
4
Contact
loqus23.com
Suite 7 Mcclintock Building, Granta Park, Great Abington, CB216GP